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Superoxide dismutases (SOD) are important anti-oxidant enzymes that guard against superoxide toxicity. Various SODenzymes have been characterized
that employ either a copper, manganese, iron or nickel co-factor to carry out the disproportionation of superoxide. This review focuses on the copper and
manganese forms, with particular emphasis on how themetal is inserted in vivo into the active site of SOD. Copper andmanganese SODs diverge greatly in
sequence and also in the metal insertion process. The intracellular copper SODs of eukaryotes (SOD1) can obtain copper post-translationally, by way of
interactions with the CCS copper chaperone. CCS also oxidizes an intrasubunit disulfide in SOD1. Adventitious oxidation of the disulfide can lead to gross
misfolding of immature forms of SOD1, particularly with SOD1 mutants linked to amyotrophic lateral sclerosis. In the case of mitochondrial MnSOD of
eukaryotes (SOD2), metal insertion cannot occur post-translationally, but requires new synthesis andmitochondrial import of the SOD2 polypeptide. SOD2
can also bind iron in vivo, but is inactive with iron. Such metal ion mis-incorporation with SOD2 can become prevalent upon disruption of mitochondrial
metal homeostasis. Accurate and regulated metallation of copper and manganese SOD molecules is vital to cell survival in an oxygenated environment.
© 2006 Elsevier B.V. All rights reserved.Keywords: Copper; Manganese; Iron; Mitochondria; ALS; Superoxide dismutase; SOD; CCS; Copper chaperone; Posttranslational modification; Disulfide
isomerase; SOD1; SOD2; EC-SOD1. Introduction
The superoxide dismutases (SODs) are ubiquitous compo-
nents of cellular antioxidant systems. As described by McCord
and Fridovich over 36 years ago, these proteins protect redox
sensitive cellular machinery from damage by catalyzing the
disproportionation of superoxide anion to oxygen and hydrogen
peroxide [1]. Several diverse families of SODs have been widely
studied and disruptions or accentuations of their function are
associated to varying degrees with several diseases in man such
as arteriosclerosis [2], diabetes mellitus [3,4] and Down
syndrome [5]. The strongest connection between SODs and
human disease is found for the copper and zinc dependent forms,
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doi:10.1016/j.bbamcr.2006.05.003amyotrophic lateral sclerosis (ALS) [6]. The activity of each of
the superoxide dismutase families relies upon a specific redox
active metal ion, and depending on the SOD molecules, this
could either be a manganese, iron, copper or nickel ion. This
brief review will focus on recent insights into the question of
how the correct metal gets into the copper- or manganese-
dependent families of these important antioxidant proteins.
All known SODs require a redox active transition metal in
the active site in order to accomplish the catalytic breakdown of
superoxide anion. A generic mechanism for the metalloenzyme-
dependent dismutation steps is below.
Moxidized−SODþ O2− ⇄Mreduced−SODþ O2
Mreduced−SOD þ O2− þ 2Hþ⇄Moxidized−SOD þ H2O2
2O2− þ 2Hþ±O2 þ H2O2
The metal cofactors catalyze both a one-electron oxidation
(see first step) and a one-electron reduction of (second step)
separate superoxide anions to give the overall disproportion-
ation reaction. These reactions typically require no external
source of redox equivalents and are thus self-contained
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function in a variety of intracellular and extracellular environ-
ments. Other antioxidant enzymes are known to consume
superoxide, such as the prokaryotic superoxide reductases
(SORs). In contrast to the SODs, these enzymes require an
external source of electrons which are typically supplied by
accessory redox proteins, such as a ferrodoxin [7]. Under some
biochemical conditions the SOD proteins can bypass the
dismutation cycle and use external redox equivalents. For
instance, catalytic SOR or superoxide oxidase (SOO) activities
have been reported for some SOD proteins; however, a
physiological role for such reaction pathways is not known [8].
Superoxide dismutases are typically soluble secreted or
cytosolic proteins but are also found in a number of subcellular
compartments such as the cell envelope of gram-negative
bacteria or the mitochondria of eukaryotic cells, as well as the
extracellular milieu. While there is no similarity in sequence or
structure between Cu/ZnSOD and Mn/FeSOD families, these
metalloproteins do share some intriguing properties. For
instance, both are quite stable relative to most proteins found
in mesophilic organisms. Members of these families of enzymes
are found across the continuum of life: examples are known in
prokaryotes, archea and eukaryotes. The Cu/ZnSODs and
MnSOD, which are the focus of this review, are the only
forms found in yeast and mammals. Excellent overviews of the
prokaryotic nickel and iron SODs can be found elsewhere [9,10].
1.1. SOD nomenclature
Before discussing the activation of the mammalian and yeast
versions of these proteins, it is useful to narrow down the
diverse SOD nomenclature otherwise observed in the literature
(Table 1). First the names for highly similar orthologs of the
various metal containing SOD molecules can vary greatly
among different species. For example, the manganese contain-
ing SOD in E. coli is known as sodA, in C. elegans as Sod-2 and
Sod-3, in C. sapidus as mtMnSOD and in bakers yeast and
mammals as SOD2. Furthermore, SOD3 refers to extracellular
Cn/ZnSOD in mammals, but to intracellular MnSOD in C.
albicans. To avoid such nomenclature confusion in this review,Table 1
Nomenclature for select SOD molecules across various species
Redox metal co-factor Name Species
Manganese sodA E. coli
Sod-2 and Sod-3 C. elegans
CytMnSOD C. sapidus
MtMnSOD C. sapidus
SOD3 C. albicans
SOD2 S. cerevisiae
Mammals
Iron sodB E. coli
Nickel NiSOD S. seoulensis
Copper Sod-1 and Sod-5 C. elegans
sodC E. coli
SOD1 S. cerevisiae Ma
SOD3 Mammalswe employ the designations Cu/ZnSOD, MnSOD and FeSOD
for all organisms other than human and yeast, where the SOD1
(intracellular Cu/Zn) and SOD2 (mitochondria MnSOD)
designations will be used.
2. Copper, zinc superoxide dismutase
2.1. Sub cellular localization of intracellular Cu/ZnSOD of
eukaryotes
SOD1 in mammals and S. cerevisiae is mainly localized in
cytosol with a smaller fraction in the intermembrane space of
mitochondria [21–25]. It has also been reported in nuclei,
lysosomes and peroxisomes using immunocytochemical meth-
ods [26]. While superoxide is produced in cytosol by several
enzymes such as xanthine oxidase [27], respiratory components
in mitochondria are thought to be a major source of O2
− gene-
ration [28]. In fact, in mammals, more than 95% of consumed
daily oxygen is reduced to water in the respiratory chain, and 1–
2% of it has been estimated to be converted to O2
− by proteins in
the electron transport chain in mitochondria. Most of mitochon-
drial O2
− is disproportionated by high levels of Mn-superoxide
dismutase (1.1×10−5 M) [29] in the mitochondrial matrix.
While the presence of SOD1 in the mitochondrial matrix is a
controversial issue [30] its localization in the inter-membrane
space (IMS) is now well established [21,23–25,31]. Interest-
ingly, in gram-negative bacteria, Cu/ZnSOD is localized in a
compartment that is distantly related to the IMS, namely the
periplasmic space [32–34]. Cu/ZnSOD is important for survival
of prokaryotes in relatively late/stationary phase and contributes
to the ability to grow aerobically [34]. The periplasmic sources
of O2
− have not yet been characterized but it is likely that Cu/
ZnSOD protects components of this compartment against both
endogenous and exogenous sources of O2
−, for instance those
arising from host pathogen responses.
Mammalian SOD1 is highly expressed in the liver and kidney
[35] and is also abundant in motor neurons [36]. Interestingly,
xanthine oxidase (which can serve as a source of superoxide) is
highly expressed in the liver. Knockout studies indicate that
elimination of the SOD1 gene in rodents is associated withLocalization Reference
Intracellular [11]
Presumed mitochondrial [12]
Cytosolic [13]
Mitochondria [13]
Cytosolic [14]
Mitochondrial matrix [15]
Intracellular [16]
Intracellular [9]
Presumed cytosolic [17,18]
Periplasmic [19]
mmals Cytoplasm and mitochondrial IMS [1]
Extracellular [20]
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infertility in females [40], age-related hearing loss via cochlear
hair cell degeneration [41], vulnerability to motor neuron loss
after axonal injury [42], and decrease in life span [39]. Also, in
humans, the level of glycated SOD1 is increased in the
erythrocytes of patients with diabetes mellitus [43]. Given that
glycation in SOD1 may cause fragmentation of the enzyme [4],
loss of SOD1 activity may lead physiological problems in
diabetic patients [3]. The most widely studied connection
between SOD1 and human diseases involves the late onset
neurodegenerative disease ALS. Over one hundred mutations in
the human gene SOD1 are now known to lead to some of the
inherited forms of ALS, and several outstanding reviews cover
the physiology and biochemical mechanisms that are under
evaluation [44–47].
2.2. SOD1 chemistry and mechanism
The structure and mechanism of this remarkable family of
proteins have been reviewed comprehensively elsewhere [48].
SOD1 is quite robust with respect to physical or chemical
denaturation; enzymatic activity is observed in the presence of
stringent denaturants such as 10 M urea or 4% SDS, and activity
in standard buffers is observed at 80 °C [49]. While thermal
(non-enzymatic) dismutation of O2
− to O2 and H2O2 is somewhat
fast under typical conditions (5×105 M−1 s−1), SOD1-catalyzed
dismutation is accelerated by four orders of magnitude and
approaches the diffusion-controlled limit (1.6×109 M−1 s−1). It
is important to note that the rate of disproportionation by these
enzymes is very similar to that of buffer solutions containing
transition metal salts. This observation led to a significant
amount of debate concerning the actual function of SOD. Recent
in vitro and in vivo studies strongly support a model for the
inorganic physiology of the cytosol in which intracellular free
zinc and copper ion concentrations are vanishingly small under
normal aerobic growth [50–54]. This is consistent with a
selection processes favoring organisms that elaborate a means of
localizing transition metal catalyst for superoxide dismutation to
different parts of the cell, depending upon the origin and nature
of the oxidative stress. Free iron, on the other hand, has been
proposed to be more available [55].
The sequence and structure of Cu/ZnSOD is highly
conserved from prokaryotes to eukaryotes [56]. This protein
associates to form a dimer with a dissociation constant of
∼1.0×10−10 M−1 [57], and each subunit has an immunoglob-
ulin-like fold that provides an active site with one copper and
one zinc ion. One remarkable feature is the intra-subunit
disulfide bond, which is stable and observed in most if not all
Cu/ZnSOD structures published to date. In the native state of
human SOD1 two of the four cysteines, namely Cys 57 and Cys
146 are oxidized to form a disulfide that stabilizes Loop IV,
which plays an important role in SOD1 dimerization. The
copper and zinc ions bind to the protein in two similar, but
chemically distinct environments. In this structure, a Cu2+ ion is
shown bound by four histidine nitrogen atoms (His 46, 48, 63,
120), forming a distorted plane, and water binds as a fifth ligand
to complete a square pyramidal structure. A bridging role isshown for His 63, which also binds to the adjacent Zn2+ ions
through the other imidazole nitrogen, which must be deproto-
nated in order to bind both metals simultaneously. Interestingly,
reduction of the Cu2+ to Cu1+ leads to a significant change in the
coordination number and geometry. Regardless of copper
oxidation state, the zinc ion binds to His 63 as well as His 71,
His 80, and Asp 83 in a distorted tetrahedral arrangement.
Binding of Zn2+ ion is not essential for the dismutation reaction
but confers higher thermal stability [58]. Similar structures are
observed for the bacterial forms of CuSOD, with a few notable
exceptions: a stable monomeric form is observed for the E. coli
protein [59], a heme binding site is observed in H. ducreyi [60],
and no clear zinc binding site is known for the M. tuberculosis
protein [61].
2.3. Insertion of copper is facilitated by the CCS
metallochaperone
It has long been known that the apo-form of SOD1 can be
generated in vitro and then reconstituted with the native copper
and zinc ions or with other metals [48]. Most cells do not leave
the insertion of copper to diffusion reactions and employ an
accessory protein known as the copper chaperone for SOD1
(CCS) to facilitate this process. CCS docks with and transfers the
metal ion to the disulfide-reduced apo SOD1 [53,62] as seen in
Fig. 1 and discussed below. Accounts of the discovery and
structure of CCS can be found in several recent reviews [63–66].
The mechanism shown in Fig. 1 reveals that CCS activates its
target SOD1 by a very different mechanism than that used by the
copper chaperone Atx1, where Cu+ is readily transferred to the
partner domains in the presence or absence of oxygen. It is now
clear that the CCS copper chaperone employs a more complex
oxygen- and disulfide-dependent mechanism. Before describing
the copper loading process, we examine the generally over-
looked intrasubunit disulfide of SOD1.
2.4. Role of the disulfide in SOD1 structure and activity
An intrasubunit disulfide is observed in all structurally char-
acterized forms of native SOD1 published to date. It appears that
SOD1 is the most abundant disulfide-containing protein in the
eukaryotic cytosol [58]. Given the reducing character of the
cytosol, most pairs of solvent exposed Cys residues would not be
expected to form a persistent disulfide. The reduction potential
for the disulfide of yeast SOD1 (E0 =−0.23 V) [58] is similar to
the resting or average reduction potential for the eukaryotic
cytosol [67]. This potential is also similar to that observed for the
protein disulfide isomerases (PDI) such as thioredoxin, where
the active site pairs of cysteines cycle between the reduced and
oxidized state (see [58] and references therein for comparisons).
Thus the robustness of this disulfide in the eukaryotic cytosol (or
in the presence of reducing buffers in vitro) is remarkable. The
physiological stability of the disulfide most likely originates
from kinetic as opposed to thermodynamic factors [58]. The
disulfide reduced form of the yeast SOD1 protein can
accumulate in the cell under anaerobic conditions or in the
absences of CCS [58,68]. This immature state of the protein is
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and apo form of the polypeptide can be imported into the IMS of
the mitochondria [21]. The presence of SOD1 in this
compartment has received considerable attention as a potential
site for neuronal damage by mutant forms of SOD1 that give rise
to ALS [23,69–73] (Fig. 2).
Recent in vitro studies have shown that reduction of the
conserved disulfide bond in human SOD1 lowers the barrier to
oligomerization and predisposes the protein to formation of
incorrect disulfide cross-links [58] and higher order aggregation
in the presence of oxidants [74]. Reduction of the disulfide also
contributes to significant global destabilization of protein
structure [74–76]. One or more of these characteristics is
significantly exacerbated in most ALS-related SOD1 mutations
mentioned above.
Several recent studies have shown that the disulfide is
essential for SOD activity and provide initial insights into how
the copper loaded form of CCS might catalyze the oxidation of
SOD to its disulfide form [45,58,68,75]. Overall, our mecha-
nism for the maturation of SOD1 involves four sequential steps
as shown in Fig. 1. The mechanism places the CCS/SOD1
complex observed in the cocrystal structure of a mutant SOD1
bound to CCS [77] on the physiological pathway for SOD
activation [58].
The disulfide may play several structural and functional
roles, but one key attribute is that changes in the disulfide status
alters the oligomerization of SOD1. The reduced protein favors
the monomeric state over the dimeric state at equilibrium. In
fact, when no metals are bound to the disulfide reduced state
human SOD1, no dimeric form is observed. Recent in vivo
studies have shown that the copper chaperone CCS controls
formation of this disulfide in an O2 responsive step [68]. TheFig. 1. Proposed mechanism of copper insertion into SOD1 by its metallochaperone,
docks with a disulfide reduced form of SOD1 (steps I and II). This complex is inert to f
disulfide-linked heterodimeric intermediate forms. An analogous complex containing
WT protein, this complex undergoes disulfide isomerization to an intramolecular disu
oxygen and the mature monomer is proposed to be released from CCS. The left side
disulfide bond has not yet formed. If the conserved Cys are oxidized to form incorreoxidizing equivalents are employed in the disulfide formation,
first leading to a heterodimeric disulfide linking Domain III of
CCS with Cys 146 of SOD1. In a subsequent step, the
intermolecular disulfide undergoes an exchange reaction in
which SOD1 Cys 56 replaces the Cys of CCS-Domain III to
form the Cys56–146 SOD1 intramolecular disulfide character-
istic of the native enzyme. At this point, it is not known whether
copper transfer into the active site precedes or is concurrent with
disulfide formation.
This oxygen-responsive disulfide process is catalyzed by
the copper form of CCS and appears to be part of a
physiological cycle that regulates the amount of active, copper
loaded SOD1protein [58]. It also modulates the half-life of the
apo reduced protein, which is thermally unstable relative to the
more mature states [74]. While the immature form of the WT
SOD1 is folded at physiological temperatures and shows little
propensity for aggregation, many of mutant forms that are
known to cause ALS are destabilized, and several are
completely unfolded at 25°C. Not all ALS mutations lead to
thermal destabilization [78]; however, all of the mutant
proteins studied to date show a great propensity to aggregate.
When the disulfide-reduced forms aggregate, the oligomeric
forms that result are exceedingly sensitive to adventitious
oxidation by even mild oxidants, such as oxidized glutathione
[74]. Interestingly mild oxidation of the ALS mutant forms of
disulfide-reduced SOD1 (but not WT) lead to insoluble
species which when solubilized with SDS and loaded onto a
nonreducing gel appear as a ladder of higher order disulfide
crosslinked SOD1 species in vitro [74]. Recently these same
phenomena have been observed in the spinal cord of
transgenic mouse models for ALS [45,79,80]. Ladders of
oxidized SOD1 from monomers to hexamers are clearlyCCS. The copper chaperone acquires copper through unknown routes and then
urther reaction unless exposed to oxygen or superoxide (step III), at which point a
mutant SOD1 has been trapped and structurally characterized. In the case of the
lfide in SOD1 (step IV). Copper is transferred at some point after introduction of
of the image depicts several immature states of the protein in which the essential
ct disulfide linkages, this can lead to SOD crosslinking and aggregation.
Fig. 2. Oxidative aggregation model for ALS-linked mutations in SOD1: competition between folding and disulfide crosslinking pathways. The lower pathway traces
the maturation of theWT SOD1, while the upper pathway depicts reactions of ALS-causingmutant SOD1. The disulfide-reduced apo-SOD1molecules emerge from the
ribosome and undergo folding and modification processes. In the case of theWT protein, the polypeptide folds and once zinc is acquired equilibrates betweenmonomer
and dimer forms. Both zinc binding and intra-molecular disulfide formation lend significant additional thermodynamic stability to the dimer (see green box), however
the enzyme is not active in the absence of copper. In contrast to the WT protein, the apo and reduced states of many ALS mutant SODs are unfolded or misfolded at
physiological temperature. The mutants studied to date are also predisposed to oligomerization when they are in the E,E-hSOD1SH state. In the presence of oxidants,
these oligomeric forms of SOD1 are susceptible to formation of disulfide-linked multimers. In this model, these oxidized multimers ultimately nucleate the formation of
larger insoluble aggregates that may contain folded or more mature forms of the protein such as those shown in the blue box. Formation of these oxidatively crosslinked
aggregates are proposed to cause neuronal cell death. Under normal conditions the cellular machinery can degrade aggregates stabilized by non-covalent interactions. If,
however, these oligomers experience even mild oxidative stress, they under go covalent crosslink formation which stabilizes the aggregates and leads to precipitation.
Once the rate of insoluble aggregate formation outpaces the rate of degradation by the cellular quality control machinery, the cell or compartment may incur damage.
Thus, any stress events that increase the expression of the most immature forms of the mutant SOD1 protein (see first branchpoint above) or otherwise increases its
concentration (for instance by reverse of the lower path) may stimulate the rate of formation of robust aggregates. This model for SOD1-linked ALS thus involves two
key steps: (a) oligomerization of misfolded reduced forms of the protein, (b) oxidation of the oligomers to form covalently linked insoluble aggregates that initiate cell
death. Recent observations provide evidence for oxidative crosslinked aggregates in mitochondria of afflicted spinal cord neurons.
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animals expressing several ALS mutant proteins, but no such
ladders are observed in mice that overexpress WT SOD1 [69].
These studies support the proposal that the build up of disulfide-
reduced SOD1, either by oxidative-stress induced expression of
newSOD1 pools or reduction of existing pools of the native protein
may lead to intermolecular disulfide adducts that seed nucleation of
insoluble aggregates that can cause neuronal toxicity[58]. Other
studies of the occurrence of detergent-resistant non-native dimers
also reported evidence of a significant amount of the disulfide
reduced SOD1 in spinal cord of mouse models and ALS patients
[81]. While these observations provide strong support for a role of
the SOD1 disulfide in ALS, there are still many mechanistic alter-
natives. It is becoming apparent that this copper chaperone does far
more than deliver copper: it has both sulfhydryl oxidase and
protein disulfide isomerase activities that appear to allow for
higher order types of physiological regulation in response to
oxidative stress.2.5. CCS independent pathways for copper-loading of SOD1
In addition to CCS, metazoan SOD1 can acquire copper by a
CCS-independent pathway. Cu/Zn SOD from humans, mouse
and C. elegans have been shown to retain activity in cells
devoid of CCS, and CCS-independent activity has been
observed with both yeast and mammalian expression systems
[18,82–85]. Although the copper donor in this case has not been
identified, CCS-independent activation of SOD1 can be
discerned from CCS by two criteria. First, CCS-independent
activation has a strict dependence on reduced glutathione or a
low redox potential of the cell [18,85]. By comparison, CCS is
reactive over a range of intracellular GSH concentrations.
Secondly, the CCS-independent pathway is sensitive to certain
structural perturbations in Cu/Zn SOD1 structure. Specifically,
prolines at SOD1 positions 142 and 144 (corresponding to S.
cerevisiae and human SOD1) prohibit CCS-independent
activation, but have no effect on CCS [18,85]. S. cerevisiae
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on CCS for acquiring copper in vivo. Yet the prevalence of such
prolines is rare among eukaryotes, and it is predicted that the
vast majority of SOD1 molecules can acquire copper by both
pathways [85]. It is noteworthy that these prolines occur near
the intrasubunit disulfide bond of SOD1 [75]. The Cu/Zn SOD
of C. elegans is unique in that it appears refractory to CCS and is
totally reliant on CCS-independent activation. In accordance
with this, there are no known CCS-encoding loci in the genome
of C. elegans [18]. Why different organisms have evolved to
employ different methods of copper acquisition is unclear but
may reflect unique lifestyle requirements for copper and
oxygen. Such evolutionary adaptations to optimize metal co-
factor capture, utilization and localization is probably not
restricted to copper and SOD1, but may be expanded to include
many aspects of metallophysiology across evolution.
2.6. Extracellular superoxide dismutase (EC-SOD)
A distinct superoxide dismutase activity is observed in the
circulatory system of many mammals. This activity arises from a
secreted copper and zinc containing enzyme encoded by the
human SOD3 gene that is related to the dimeric Cu,Zn SOD
family described above. EC-SOD is typically made in vascular
smooth muscle cells and secreted into the extracellular
environment where it binds to extracellular matrix and
endothelial surface components [20]. Its postulated functions
include prevention of superoxide-dependent inactivation of
endothelial cell enzymes and products including nitric oxide.
The central core of EC-SOD polypeptide is homologous to
SOD1 but possesses extensions at the N- and C-termini. Unlike
SOD1, it forms stable tetramers with interchain disulfides that
stabilize the quaternary structure [86]. The copper-loading
pathways for EC-SOD are also quite different from those
observed for SOD1. The secreted EC-SOD protein appears to
be loaded with copper in CCS-independent intracellular steps
that occur within the secretory compartments. The latter
compartments utilize the Atox1 copper chaperone pathway
[20,87]. Atox1, also known as HAH1, is the human homologue
of the first example of a copper chaperone, namely Atx1. This
small protein is a diffusable copper binding protein which
docks specifically with the cytosolic domain of the Menkes
disease protein, an integral membrane P-type ATPase proteins
which transport Cu+1 across vesicular membranes into
secretory compartments in both yeast and mammalian cells
[88]. Several reviews of these mechanisms can be found
elsewhere [51,64,66,89].
3. Manganese superoxide dismutase
3.1. The well conserved family of manganese and iron
containing SODs
The family of MnSOD or FeSOD enzymes first discovered
by Fridovich [11,16] has been well conserved throughout
evolution. Across various phyla of archae, eubacteria and
eukaryotes, the family of Mn/Fe SODs is comprised of dimersor tetramers of ≈21 kDa subunits with considerable sequence
homology and well conserved protein folds (reviewed in [10]).
Within each subunit, a single manganese or iron atom bound at
the active site serves to catalyze the disproportionation of
superoxide to oxygen and hydrogen peroxide. Regardless of
whether the cofactor is manganese or iron, the metal is buried
well within the protein interior and co-ordinated in a trigonal
bipyramidal geometry to three histidines, one aspartate and a
solvent water molecule.
Based on 261 aligned sequences and 12 X-ray structures, two
phenetic trees of Mn/Fe SODs have been constructed, and a clear
distinction has been made for dimeric and tetrameric SODs (for
details see [10]). Dimeric forms of MnSOD or FeSOD are typical
of bacteria, and inmany organisms (e.g., E. coli) bothmetal forms
are expressed in the same cell. A limited number of prokaryotes,
especially hyperthermophiles, express tetrameric Mn- or FeSOD
enzymes [10]. Eukaryotes in general harbor only MnSOD as a
tetramer; FeSOD is commonly absent from eukaryotes.
3.2. Promiscuity in metal binding of Fe and MnSODs
Based on the close homology of manganese and iron SODs,
one might expect facile metal co-factor substitution. Indeed,
Whittaker has shown that the MnSOD of E. coli binds iron with
affinities equal to that of manganese [90]. Metal mis-
incorporation with bacterial MnSODs has also been observed
in vivo. MnSOD of E. coli is expressed as a mixture of
manganese and iron bound forms [91], and iron binding to
MnSOD increases during anaerobic conditions and when
extracellular iron is abundant [92,93]. The tetrameric MnSOD
from Thermophilus also binds both manganese and iron when
expressed in E. coli [92], and recombinant FeSOD from A.
ambivalens can associate with cobalt, nickel or manganese
depending on the extracellular environment of the E. coli host
[94]. It has been proposed that metal selectivity in the bacterial
Fe/Mn SOD molecules is determined by the differential
bioavailability of manganese versus iron in the cell [90].
Although bacterial Fe/Mn SOD molecules can bind non-
native metals with high affinity, they are very specific with
regard to metal-catalyzed reactivity. MnSOD molecules are
inactive with iron at the active site, and the same is true for Mn-
loaded FeSOD. This would seem surprising based on the
virtually identical metal binding sites for Mn and FeSODs [92].
However, slight differences in the outer sphere of the metal site
may be critical [92] which in turn affect redox potential of the
catalytic site [95,96]. SOD enzymes are efficient at dispropor-
tionating superoxide simply because the redox potential of the
metal site (+200 to +400 mV) lies between that of oxygen/
superoxide (−160 mV) and superoxide/hydrogen peroxide
(+890 mV). In MnSOD, the active site environment has been
fine-tuned to accommodate manganese, and iron binding lowers
the redox potential to a level that cannot complete the
disproportionation reaction [95,96].
It is worth mentioning that the metal ion promiscuity of Fe/
Mn SODs is highly irregular among metalloproteins. To our
knowledge, this represents the only documented case of metal
ion misincorporation in a metalloenzyme expressed phys-
Fig. 3. Role for mitochondrial import in metallation of SOD2. Shown is a model
by which the translation, mitochondrial import and metal insertion of SOD2 are
coupled. As the polypeptide enters mitochondria, SOD2 remains sufficiently
unfolded to allow manganese insertion. Following manganese binding and
complete entry into the mitochondrial matrix, the polypeptide can assemble into
the quaternary enzyme. The mitochondrial carrier transporter Mtm1p helps
prevent iron from interacting with SOD2. The substrate for transport by Mtm1p
is unknown. Mitochondrial manganese is derived from intracellular vesicles
harboring the Nramp manganese transporter, Smf2p.
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insertion typically inactivate enzymes and can have a detrimen-
tal effect on the cell. In the case of bacterial MnSOD, it is
possible that metal ion misincorporation serves in a regulatory
mode to down regulate enzyme activity under conditions of low
need, e.g., under anaerobic conditions.
While metal ion misincorporation seems wide spread with
bacterial MnSOD, the MnSOD of eukaryotic mitochondria
(SOD2) appears highly metal specific. Until recently, there have
been no reports of iron association with eukaryotic SOD2. SOD2
is the sole SOD of the mitochondrial matrix and loss of
mitochondrial SOD2 is known to have severe consequences on
organism survival [97–102]. Eukaryotes have therefore evolved
with methods for largely preventing iron incorporation into
SOD2. Yet as described below, when cellular iron or manganese
homeostasis is disrupted, changes in metal ion bioavailability
can lead to iron insertion in eukaryotic SOD2 as well. The
mechanism by which eukaryotic SOD2 acquires its manganese
co-factor and the effects of iron homeostasis on SOD2 activity
will be the subject of the remaining discussion.
3.3. Manganese insertion into SOD2 requires mitochondrial
import of the polypeptide
In eukaryotes, the manganese form of SOD generally resides
in the matrix of the mitochondria. Rare exceptions include the
cytosolic MnSODs of the fungi C. albicans [14] and crustaceans
[13]. The mechanism by which these cytosolic enzymes acquire
their manganese co-factor is unknown. In this review, we shall
highlight recent advances made in understanding the manganese
activation steps for the mitochondrial SOD2.
In all known cases of SOD2, the polypeptide is encoded by
a nuclear gene and is imported into the mitochondrial matrix.
SOD2 is synthesized as a precursor polypeptide containing, at
its N-terminus, a pre-sequence for mitochondrial targeting that
is subsequently cleaved in mitochondria. We engineered a
mutant form of S. cerevisiae SOD2 that lacks this mitochon-
drial pre-sequence. [The yeast protein is denoted as Sod2p.]
The modified Sod2p polypeptide accumulated in the cytosol
rather than mitochondria, and was enzymatically inactive.
Lack of activity reflected manganese deficiency in the
enzyme, because activity was restored upon culturing yeast
cells in medium containing high manganese [103]. These
studies demonstrated that Sod2p requires a mitochondrial
localization to efficiently acquire manganese.
Is manganese inserted into a pre-existing pool of apo SOD2?
As described in the accompanying section of this chapter, the
Cu/Zn containing SOD1 of eukaryotes can exist as an apo
enzyme that is readily activated by copper without new protein
synthesis [68,104,105]. However, the same is not true for
manganese SOD2. Using S. cerevisiae Sod2p as a model, we
noted that metal activation requires protein translation and that
manganese insertion only occurs with newly synthesized Sod2p
molecules that are freshly imported intomitochondria [103]. The
ribosomes for SOD2 translation are juxtaposed on the outer
membrane of mitochondria [106,107], which allows for tight
coupling of translation and mitochondrial import of SOD2[103]. Our studies are consistent with a model in which the
mitochondrial import process facilitates manganese insertion
into SOD2 (see Fig. 3).
Why would mitochondrial import be necessary for co-factor
insertion? In studies of the highly homologous bacterial
MnSOD, metal insertion requires a temperature-dependent
switch in SOD structure. At ambient temperatures, MnSOD
molecules largely exist as conformers where metal access to the
active site is blocked by steric and electrostatic constraints
[90,108]. However, a specific switch from this “closed” to an
“open” conformation allows manganese entry. Such a switch in
conformation can be induced in the test tube by elevations in
temperature [90,108,109]. Yet in living cells, other forces for
disrupting SOD structure must be at play. What better way to
disrupt protein structure than to pass it through a biological
membrane? During co-translational import of SOD2 into
mitochondria, the polypeptide may remain sufficiently unfolded
to facilitate manganese insertion (as in Fig. 3). Alternatively, an
accessory factor may contain SOD2 in the unfolded state during
import to allow rapid manganese insertion prior to SOD2
folding [103]. Overall, the mitochondrial import process
provides an excellent evolutionary advantage to overcoming
the physical barriers associated with manganese binding to
SOD2.
3.4. Membrane transporters that facilitate manganese insertion
into SOD2
Through yeast molecular genetics, we have identified two
membrane transporters that are needed for manganese traffick-
ing to SOD2. These include the Smf2p manganese transporter
and Mtm1p, a member of the mitochondrial carrier family of
transporters.
Fig. 4. Metal binding to SOD2 is determined by the differential bioavailability of iron versus manganese. Shown is a model for how changes in mitochondrial iron and
manganese homeostasis can change metal specificity in SOD2. Under normal conditions, mitochondrial iron is in vast excess over total mitochondrial manganese (by
1–2 orders of magnitude), but this iron largely exists in a “SOD2-inert” state (green boxes) that is unavailable to SOD2. The small fraction of “SOD2-reactive” iron
(red circles) cannot compete well with manganese (violet circles) for binding to SOD2. However, with disruptions in iron homeostasis caused bymtm1mutations or by
specific defects in Fe–S cluster assembly, SOD2-reactive iron levels substantially rise, and this iron competes well with manganese for binding to SOD2. Under
manganese deficiency conditions, the small level of SOD2-reactive iron gains access to the active site of SOD2.
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Smf2p is one of twoNrampmetal transporters that function in
manganese uptake and trafficking in S. cerevisiae. In smf2Δ null
yeast mutants, mitochondrial manganese levels are very lo
h elevated, but non-toxic concentrations of manganese (e.g.,
5 μMMnCl2 added to the growth medium that has no inhibitory
effect on yeast cell growth) [110].
The effect of smf2 mutations on manganese is not unique to
mitochondria. The cytosol of smf2Δmutants is also manganese-
deficient, and manganese-dependent sugar transferases in the
secretory pathway are inactive in smf2 mutants [110]. This cell-
wide deficiency in manganese suggests that Smf2p is important
for cell surface uptake of manganese. However, to date there is
no evidence that Smf2p resides at the plasma membrane, only at
an intracellular vesicular localization of unknown origin [110].
The effect of smf2Δ mutations on cell surface uptake of
manganese is either indirect or involves a small fraction of
plasma membrane Smf2p that escapes detection.
In smf2 mutants, the Sod2 polypeptide stably accumulates
in the mitochondria in a manganese-deficient form. This pool
of “apo” Sod2p cannot be activated by manganese, due to the
aforementioned requirement for new protein synthesis in
manganese insertion [103]. But is this enzyme really apo
with respect to metal content or just manganese deficient? In
our recent studies, we find that the Sod2p of smf2 mutants is in
fact bound to iron [111]. Most likely, mitochondrial SOD2
never accumulates in the fully apo form, but binds to either
manganese or iron depending on which metal is more
bioavailable.
3.4.2. MTM1
Mtm1p is a member of the mitochondrial carrier family
(MCF) of transporters. MCF transporters (≈30–40 distinct
forms) all reside in the mitochondrial inner membrane and
function to exchange solutes between the mitochondria and
cytosol [112].We identified S. cerevisiae MTM1 as a gene which
when deleted, resulted in Sod2p inactivation due to manganese
deficiency in the enzyme [113].We surmised that Mtm1p might serve as the manganese
transporter for the mitochondria or a manganese trafficking
factor for MnSOD, hence the name Mtm1p. As with smf2
mutants, Sod2p activity in mtm1Δ cells could be restored by
supplementing the growth medium with manganese. However,
unlike smf2 mutants, the manganese levels required to restore
Sod2p activity in mtm1 mutants was exceedingly high,
approaching cytotoxic quantities [113]. As such, Sod2p
inactivation in mtm1 mutants was not likely to result from a
simple deficiency in mitochondrial manganese. In fact, our
analysis revealed that mitochondrial manganese was somewhat
higher than normal in mtm1 mutants [113]. Yet this manganese
cannot bind to Sod2p.
Mtm1p is clearly not the manganese transporter for the
mitochondria and to date, the substrate for transport by Mtm1p
remains elusive. In any case, Mtm1p plays a critical role in
mitochondrial metal homeostasis and as described below, the
Mtm1p effects on bioavailability of manganese versus iron
greatly impacts on Sod2p activity.
3.5. Mistakes in metal ion incorporation in eukaryotic SOD2
As mentioned above, bacterial forms of MnSOD readily
associate with iron in vivo, however a similar mis-incorporation
of iron has not been reported for eukaryotic SOD2. Based on the
strong homology between bacterial and eukaryotic MnSOD
enzymes, one might expect SOD2 to bind iron with affinities
similar to that of manganese. In addition, the levels of total
mitochondrial iron exceed manganese by 1 to 2 orders of
magnitude [114]. How then does SOD2 manage to avoid
interactions with iron? In the following, we provide evidence
that iron can indeed associate with SOD2, particularly when
mitochondrial iron homeostasis is disrupted.
The first clue of iron association with SOD2 was obtained
during analysis of mtm1 yeast mutants defective in Sod2p
activity. These mutants were seen to hyperaccumulate iron in
both the mitochondria and cytosol [113]. Such iron accumula-
tion without exposure to high environmental iron is reminiscent
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in Fe–S cluster biosynthesis (reviewed in this issue by R. Lill).
Although we have no evidence to date that Mtm1p functions in
Fe–S cluster synthesis [111], Mtm1p nevertheless is playing a
critical role in mitochondrial iron homeostasis.
The elevation in mitochondrial iron of mtm1 mutants ranges
from 2 to 5 fold depending on the yeast strain or growth
conditions, but regardless of this variation in iron levels, the
mitochondrial iron of mtm1 mutants is toxic to Sod2p. Sod2p
activity of mtm1 mutants is rescued by depleting mitochondrial
iron through either iron chelator treatment or by mutating the
Aft1p transcription factor [115] for iron uptake in yeast.
Moreover, mitochondrial fractionation and ICP analysis
demonstrates that in mtm1 mutants, iron binds to Sod2p, not
manganese [111]. As with bacterial MnSOD, iron binding to
eukaryotic SOD2 irreversibly inactivates the SOD enzyme.
Iron inactivation of mitochondrial Sod2p is not unique to
mtm1 mutants and was also seen with certain isc mutants
defective in mitochondrial Fe–S cluster synthesis. By compar-
ison, treatment of wild type yeast with high environmental iron
did not inactivate Sod2p in spite of elevated iron levels [111].
Overall, these studies have led us to conclude that mitochondrial
iron exists in at least two states. Normally the bulk of
mitochondrial iron in wild type cells exists in a “SOD2-inert”
form that is inaccessible to SOD2. Mitochondrial manganese is
more bioavailable and as a result, SOD2 is assembled in the
manganese-bound, enzymatically active state. However, certain
disruptions in mitochondrial iron homeostasis can lead to a
change in iron bioavailability and a “SOD2-reactive” form of
iron accumulates (Fig. 4). This iron pool is so accessible to
SOD2 that it takes extremely high elevations in mitochondrial
manganese to out-compete iron for binding to SOD2 [111]. It is
noteworthy that a small pool of “SOD2-reactive” iron also exists
under normal iron homeostasis conditions. In wild type yeast
cells, a minor fraction of iron can be seen associating with
Sod2p. And as described above, iron readily associates with
yeast Sod2p when mitochondrial manganese is low, as in smf2
mutants [111] (Fig. 4). Currently the precise nature of SOD2-
reactive versus SOD2-inert iron is unknown but may reflect
changes in oxidation state or ligand complexes of the metal. It is
unlikely that free ionic manganese and iron serve as the source of
metal for SOD2, but rather the metals exist as available organic
or inorganic complexes.
4. Outlook
The copper and zinc dependent SODs play important, but not
necessarily essential, roles in protecting components of the
bacterial cell envelope or one of the many compartments of
eukaryotic cells. In addition, there is accumulating evidence that
copper dependent SODs play roles in signal transduction path-
ways. For instance, the EC-SOD enzyme can modulate the half-
life of endothelial-derived nitric oxide in regions of the
vasculature where superoxide levels would otherwise inactivate
this important signal molecule by forming peroxynitrite [116].
The products of superoxide dismutation, i.e. hydrogen peroxide
and oxygen, may also play direct signaling roles in theintracellular milieu as well [117]. With these more complex
SOD functions in mind, it is not surprising that numerous
posttranslational mechanisms for regulating SOD activity in
response to physiological signals are beginning to emerge [68].
Intriguingly, metal insertion, proteolytic processing and disul-
fide formation are important posttranslational modifications that
alter SOD1 and/or EC-SOD activity. The factors such as CCS
that are involved in SOD1 modifications may be employed in
different physiological contexts, depending upon the degree of
oxidant stress, nutritional copper availability [118] or the local
signaling requirements of specialized cells. It will be interesting
to see how these and other metal-specific posttranslational
modification pathways play a part in metabolic, neurodegener-
ative and vascular diseases.
In contrast to the copper-requiring SODs, the manganese
containing SOD2 of the mitochondria plays an essential role in
oxidative stress protection. Complete loss of the enzyme results
in neonatal lethality in mice [102] and is also critical for growth
and viability of other eukaryotic organisms [98,99]. Even
haploinsufficiency of SOD2 can be detrimental [97,119]. As
such, the precise assembly of SOD2 into a mature tetrameric,
manganese-containing enzyme is critical for aerobic survival.
Mammalian candidate homologs to Smf2p [120] and Mtm1p
[113] have been identified, and these may play an important role
in ensuring proper activation of mammalian SOD2 as well.
While many key findings have emerged from studies in S.
cerevisiae, the picture is far from complete. We still do not
understand how manganese enters the mitochondria or how
mitochondrial iron is largely maintained in a bio-unavailable
state with regard to SOD2. The substrate for transport by
Mtm1p is still elusive, and current studies are aimed at
understanding how disruptions in mitochondrial iron homeo-
stasis by mtm1 mutations increases iron bioavailability to
Sod2p. These studies on the promiscuous metal binding by
SOD2 can have important implications with regard to human
disorders of oxidative stress and iron overload. A number of
iron overload diseases have been associated with severe
oxidative damage [121,122]. It is generally believed that high
iron causes oxidative stress mainly through iron catalyzed
Fenton chemistry. However, our recent analyses of SOD2
suggest a new component to iron toxicity: inactivation of an
important mitochondrial anti-oxidant enzyme. Future studies of
iron overload disorders should consider effects on SOD2 as a
potential etiologic agent.
Finally, the studies on the various metal containing SODs
raise questions about the evolution of SOD catalysts. It is quite
possible that environmental metal ion availability and cell
physiology have played important roles in determining the
nature of the specific metal ion and SOD-type used in
scavenging toxic superoxide anion.References
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